Case Studies

Submit Your Resume

Submit Your Resume

Submit Your Resume

POSTERS

• Comparative Efficacy, Safety, Tolerability, And Effectiveness Of Antipsychotics In The Treatment Of Dementia Related Psychosis (DRP): A Systematic Literature Review (Clinical Trials on Alzheimer’s Disease Conference, 2020, Acadia Pharmaceuticals, Psychiatry)
• Economic Burden of Dementia Related Psychosis Among Medicare Beneficiaries: A State-Transition Markov Analysis of Total Annual Direct Costs (Neuroscience Education Institute, 2020, Acadia Pharmaceuticals, Psychiatry)
• Cost of Illness Analysis of Dementia-Related Psychosis in the US from a Societal Perspective (The Professional Society for Health Economics and Outcomes Research, 2020, Acadia Pharmaceuticals, Psychiatry)
• Prevalence Of COVID-19 Vs. Seasonal Influenza: A Population-Based National Survey Of US Adults (The Professional Society for Health Economics and Outcomes Research, 2020, Anlitiks)
• Economic Burden of Dementia Related Psychosis Among Medicare Beneficiaries: A State-Transition Markov Analysis of Total Annual Direct Costs (Academy of Managed Care Pharmacy Nexus, 2020, Acadia Pharmaceuticals, Psychiatry)
• Treatment-Emergent Adverse Event-Related PPPY Costs: Analysis Of Medicare Beneficiaries Treated With Off-Label Atypical Antipsychotics For Dementia-Related Psychosis (Neuroscience Education Institute, 2021, Acadia Pharmaceuticals, Psychiatry)
• Cost of Illness Analysis of Dementia-Related Psychosis in the US from a Societal Perspective (American Society of Consultant Pharmacist Conference, 2021, Acadia Pharmaceuticals, Psychiatry)
• Comparative Effectiveness of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis (American Psychiatric Association Annual Meeting, 2021, Acadia Pharmaceuticals, Psychiatry)
• Treatment Emergent Adverse Events And Associated AE-Specific PPPY Costs: Analysis Of Medicare Beneficiaries Treated With Off-Label Atypical Antipsychotics For Dementia Related Psychosis (US Psych Congress, 2021, Acadia Pharmaceuticals, Psychiatry)
• Incremental Cost Of Treatment Emergent Falls/Fractures, Stroke And CVAEs Among Patients On Atypical Antipsychotics: Analysis Of Medicare Patients With Dementia Related Psychosis (US Psych Congress, 2021, Acadia Pharmaceuticals, Psychiatry)
• Incremental Cost Of Suboptimal Treatment Outcomes Among Patients With Dementia-Related Psychosis: Analysis Of Medicare Beneficiaries (US Psych Congress, 2021, Acadia Pharmaceuticals, Psychiatry)
• Gradual Dose Reduction Patterns And Continuity Of Care Among Pimavanserin Users In Long Term Care Settings: Analysis Of Part D Claims Linked With Minimum Data Set (MDS) 3.0 (American Society of Consultant Pharmacist Conference, 2021, Acadia Pharmaceuticals, Psychiatry)
• Incremental Cost Of Catheter-Related Blood Stream Infections Among Central Venous Catheter Dependent Hemodialysis Patients: A Claims-Based Assessment Of USRDS-Linked Medicare Data (Academy of Managed Care Pharmacy Nexus Conference, 2021, CorMedix, Nephrology)
• Catheter-Related Bloodstream Infections Incidence And Associated Mortality Risk: Analysis Of Merged United States Renal Data System-Medicare Claims (American Society of Nephrology Conference, 2021, CorMedix, Nephrology)
• Hospitalization Risk And Long-Term Complications Associated With Catheter-Related Bloodstream Infections Among Hemodialysis Patients (American Society of Nephrology Conference, 2021, CorMedix, Nephrology)
• Chimeric Antigen Receptor T-Cell Therapy Treatment Patterns: A Retrospective Cohort Analysis Of Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Patients In The US (American Society of Hematology Conference, 2021, Kite Pharma, Oncology)
• Antipsychotic Medication Review Documentation And Pimavanserin Treatment-Continuity On Outcomes: Analysis Of Minimum Data Set 3.0 Linked With Part D Claims (AMDA-The Society for Post-Acute and Long-Term Care Medicine, 2022, Acadia Pharmaceuticals, Psychiatry)
• Efficacy, Safety, and Acceptability Of Atypical Antipsychotics In Treating Parkinson’s Disease Psychosis: A Systematic Literature Review (American Geriatric Society Annual Meeting, 2022, Acadia Pharmaceuticals, Psychiatry)
• Rapid Incidence and Emergence of Catheter-Related Blood Stream Infections (CRBSIs) Among CVC-Dependent HD Patients (American Society of Nephrology Conference, 2022, CorMedix, Nephrology)
• Mortality Risk and Long-Term Complications Associated with Cather-Related Bloodstream Infections (CRBSIs) (American Society of Health System Pharmacists, 2022, CorMedix, Nephrology)
• Risk of Long-term Care Admissions Among Medicare Patients Treated with Pimavanserin vs. Atypical Antipsychotics for Parkinson’s Disease Psychosis (International Parkinsons and Movement Disorder Society International Congress, 2022, Acadia Pharmaceuticals, Psychiatry)
• ER Visits and Hospitalizations Among Patients Treated with Pimavanserin or Other-AAPs for Parkinson’s Disease Psychosis: Analysis of Medicare beneficiaries (International Parkinsons and Movement Disorder Society International Congress, 2022, Acadia Pharmaceuticals, Psychiatry)
• ER Visits and Hospitalizations Among Patients Treated with Pimavanserin or Other-AAPs for Parkinson’s Disease Psychosis: Analysis of Medicare beneficiaries (American Society of Clinical Psychopharmacology Annual Meeting, 2022, Acadia Pharmaceuticals, Psychiatry)
• Cost Analysis of Maribavir Versus Investigator-Assigned Treatment for Post-Transplant Cytomegalovirus Infections in a Phase 3 Trial (Academy of Managed Care Pharmacy, 2022, Takeda Pharmaceuticals, Infectious Disease)

abstracts

• ·Acceptability Of Atypical Antipsychotics In Treating Parkinson’s Disease Psychosis: A Systematic Literature Review (American Geriatric Society Annual Meeting, 2022, Acadia Pharmaceuticals, Psychiatry)Economic Burden of Dementia Related Psychosis Among Medicare  Beneficiaries: A State-Transition Markov Analysis of Total Annual Direct Costs (Neuroscience Education Institute, 2020, Acadia Pharmaceuticals, Psychiatry)